ChemoCentryx, Inc.
CCXI · NASDAQ
6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $44 | $41 | $50 | $94 |
| Short-Term Investments | $284 | $300 | $215 | $176 |
| Receivables | $5 | $3 | $0 | $20 |
| Inventory | $5 | $3 | $1 | $0 |
| Other Curr. Assets | $6 | $5 | $3 | $4 |
| Total Curr. Assets | $345 | $352 | $269 | $293 |
| Property Plant & Equip (Net) | $55 | $56 | $57 | $58 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $18 | $31 | $98 | $102 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $2 | $2 | $1 |
| Total NC Assets | $74 | $89 | $156 | $161 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $419 | $440 | $426 | $455 |
| Liabilities | – | – | – | – |
| Payables | $8 | $5 | $7 | $4 |
| Short-Term Debt | $23 | $22 | $19 | $17 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $21 | $19 | $11 | $16 |
| Other Curr. Liab. | $25 | $23 | $26 | $23 |
| Total Curr. Liab. | $76 | $69 | $63 | $60 |
| LT Debt | $49 | $51 | $5 | $56 |
| Deferred Rev, NC | $57 | $62 | $25 | $21 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $47 | $1 |
| Total NC Liab. | $107 | $113 | $77 | $79 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $183 | $182 | $140 | $139 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$687 | -$656 | -$617 | -$577 |
| AOCI | -$2 | -$2 | -$0 | -$0 |
| Other Equity | $926 | $916 | $904 | $892 |
| Total Equity | $237 | $259 | $286 | $316 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $419 | $440 | $426 | $455 |
| Net Debt | $28 | $32 | -$26 | -$21 |